Patent Assignment
Reel/Frame 060908/0852
Change of Name
Recorded: 2022-08-26
Pages: 2
Assignor
TEKMIRA PHARMACEUTICALS CORPORATION
Executed: 2015-07-31
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
Methods of Delivering Oligonucleotides to Immune Cells
Application:
17/244,445 →
Publication:
US 2022/0079970
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 23, 2022
From: NOVOBRANTSEVA, TATIANA; AKINC, AKIN; SUGO, TSUKASA
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 059983/0009 →
Assignment of Assignor's Interest
Aug 9, 2022
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 060759/0665 →
Merger
Sep 9, 2022
From: PROTIVA BIOTHERAPEUTICS, INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 061406/0499 →